metformin has been researched along with Spondylitis, Ankylosing in 1 studies
Metformin: A biguanide hypoglycemic agent used in the treatment of non-insulin-dependent diabetes mellitus not responding to dietary modification. Metformin improves glycemic control by improving insulin sensitivity and decreasing intestinal absorption of glucose. (From Martindale, The Extra Pharmacopoeia, 30th ed, p289)
metformin : A member of the class of guanidines that is biguanide the carrying two methyl substituents at position 1.
Spondylitis, Ankylosing: A chronic inflammatory condition affecting the axial joints, such as the SACROILIAC JOINT and other intervertebral or costovertebral joints. It occurs predominantly in young males and is characterized by pain and stiffness of joints (ANKYLOSIS) with inflammation at tendon insertions.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Qin, X | 1 |
| Jiang, T | 1 |
| Liu, S | 1 |
| Tan, J | 1 |
| Wu, H | 1 |
| Zheng, L | 1 |
| Zhao, J | 1 |
1 other study available for metformin and Spondylitis, Ankylosing
| Article | Year |
|---|---|
Effect of metformin on ossification and inflammation of fibroblasts in ankylosing spondylitis: An in vitro study.
Topics: AMP-Activated Protein Kinases; Animals; Biomarkers; Case-Control Studies; Cell Culture Techniques; F | 2018 |